Patient-preferred Aromatherapy Versus Placebo For Reducing Preoperative Anxiety In Patients Undergoing Eye Surgery
RELAAC
1 other identifier
interventional
64
1 country
1
Brief Summary
This study looks at whether aromatherapy (scent chosen by the patient), is better than routine care, at reducing preoperative anxiety before eye surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 26, 2025
CompletedFirst Posted
Study publicly available on registry
November 19, 2025
CompletedNovember 19, 2025
June 1, 2025
1.1 years
June 26, 2025
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in VAS scores for preoperative anxiety
preoperative anxiety was ranked by the patient on a scale of 0-100 on a visual acuity scale (VAS) measuring 100mm, in the preoperative ambulatory ward, before and after the intervention/placebo was applied for at least 30 minutes. The change in the VAS score at these 2 timepoints was the primary outcome
30-60 minutes
Study Arms (2)
placebo
PLACEBO COMPARATORPatients were asked to choose amongst 4 different aromatherapy scents. The study administrator then stuck an adhesive patch without any aromatherapy oil on it, to the patient's facemask. This was worn throughout the perioperative experience from the ambulatory ward to the operating theatre and post anaesthesia care unit (PACU).
intervention
EXPERIMENTALPatients were asked to choose amongst 4 different aromatherapy scents. The study administrator then stuck an adhesive patch with 1 drop of their chosen aromatherapy oil on it, to the patient's facemask. This was worn throughout the perioperative experience from the ambulatory ward to the operating theatre and post anaesthesia care unit (PACU).
Interventions
patients chose their preferred aromatherapy scent to be used for at least 30 minutes
Eligibility Criteria
You may qualify if:
- mental capacity for informed consent
- undergoing elective ambulatory eye surgery (including Phacoemulsification, Femtosecond laser-assisted cataract surgery (FLACS), Extracapsular cataract extraction (ECCE) and vitrectomy).
- surgery only under Monitored Anaesthesia Care (MAC)3
- surgical duration less than 45 minutes
You may not qualify if:
- anosmia
- allergy to aromatherapy oil
- asthma
- allergic rhinitis
- psychiatric disease
- altered mental state
- lack of mental capacity
- active infection
- pregnancy
- patient or surgeon refused participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital Singapore
Singapore, Singapore
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2025
First Posted
November 19, 2025
Study Start
March 1, 2023
Primary Completion
March 31, 2024
Study Completion
December 1, 2024
Last Updated
November 19, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
local Patient Data Protection Act